1. Home
  2. EMAT vs ALMR Comparison

EMAT vs ALMR Comparison

Compare EMAT & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolution Metals & Technologies Corp. Common Stock

EMAT

Evolution Metals & Technologies Corp. Common Stock

N/A

Current Price

$0.93

Market Cap

2.6B

Sector

N/A

ML Signal

N/A

Logo Alamar Biosciences Inc. Common Stock

ALMR

Alamar Biosciences Inc. Common Stock

N/A

Current Price

$30.73

Market Cap

2.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
EMAT
ALMR
Founded
N/A
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
EMAT
ALMR
Price
$0.93
$30.73
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$8.25
★ $37.00
AVG Volume (30 Days)
★ 787.6K
728.8K
Earning Date
08-17-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$64.80
Revenue Next Year
$3,807.38
$37.27
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.96
$21.58
52 Week High
$17.50
$39.61

Technical Indicators

Market Signals
Indicator
EMAT
ALMR
Relative Strength Index (RSI) 31.48 52.11
Support Level N/A $23.87
Resistance Level $1.69 $37.81
Average True Range (ATR) 0.27 2.56
MACD -0.03 0.20
Stochastic Oscillator 1.82 56.19

Price Performance

Historical Comparison
EMAT
ALMR

About EMAT Evolution Metals & Technologies Corp. Common Stock

Evolution Metals & Technologies Corp is a critical materials and technology company. The company is focused on developing a secure, dependable, and self-sustaining U.S.-aligned supply chain for critical minerals and materials (CMM), and rare earth elements (REEs). The company is also engaged in recycling end-of-life materials through urban mining to help strengthen domestic resource independence and long-term supply stability.

About ALMR Alamar Biosciences Inc. Common Stock

Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

Share on Social Networks: